A must read about HCI below read it and u will bet
Post# of 85497
$UNVC/AGRIMED/SATIVEO/HCI to .50
https://www.hempci.com/about
Quote:
Hemp Commodity Industries
HCI was founded by scientists and business professionals dedicated to implementing hemp as a primary component of major industrial applications. As scientists, we understand the inherent strengths of the plant and its superiority over traditional products. As business professionals, we are motivated by the value those strengths bring to the products we use every day as consumers.
We are a full-lifecycle company, having created the commercial need for each part of the plant, leaving nothing behind. No waste is the ancient approach, and HCI is preserving and reintroducing this method. We are proliferating a new industry founded on an ancient crop, and HCI is leading the way in innovation. We are the future scientists, evangelists, and innovators of this industry. We are the future of hemp.
HCI has a national focus on growing their hemp crops launching in Maine, Maryland, Michigan and South Carolina. As leading advocates for hemp adoption, HCI is also serving as a broker and distributor in partnership with large and small hemp producers. HCI is thoroughly invested in the hemp industry, we envision hemp products dramatically improving peoples lives globally, touching every aspect of modern life from improving the environment, to health and wellness, to nutrition and industrial uses. The future of hemp is limitless!
Our Team
Roy "Chip" Ellis, President
Roy "Chip" Ellis is the President of Hemp Commodity Industries, LLC. Mr. Ellis is the Co-founder Ellis Development Group, and founder of Ellis Enterprises LLC, a real estate development services company. Ellis Enterprises, LLC, has worked in the Washington, DC. market on various commercial and residential real estate development projects including mixed use developments and historic restorations. As a result of these efforts both companies, has created approximately one million square feet of residential and commercial space with an asset value over $400,000,000.
As President of Hemp Commodity Industries, LLC, Mr. Ellis is a firm believer that hemp is one of the most exciting lifestyle products in the marketplace today. Industrial hemp and CBD offer compelling solutions and products throughout the consumer service industry including: nutritional, medicinal, environmental and industrial. Mr. Ellis is committed to being part of the new economic revolution of industrial hemp which will greatly surpass all revenue and market projections of the recreational and medicinal cannabis sister plant widely known as marijuana.
Eric Mitchell MD, FACPE, CEO
Eric Ignatius Mitchell, MD, MA, FACPE, CPE, is the Chief Executive Officer of Hemp Commodity Industries, LLC. He is a former orthopedic surgeon and sports medicine doctor. He now specializes in pain management for PTSD and TBI.
He holds a master’s degree in international relations from Salve Regina University and is a graduate of The U.S. Army War College. The Colonel (ret.) commanded two combat support hospitals, and served globally as Inspector General for the DOD.
Dr. Mitchell completed his medical training at the Perelman School of Medicine of the University of Pennsylvania. This included a Fellowship in Orthopedic Research with multiple published articles in peer review journals.
He is a Fellow of the American College of Physician Executives.
Dr. Mitchell was SVP of Medical Affairs at a local healthcare system in Philadelphia. His community service includes serving on several Boards of Directors.
Dr. Mitchell has traveled and lectured globally. He also contributes his medical expertise to local radio and television shows. He is also the author of Cannabis Sativa the Truth Be Told: Good Research = Good Outcomes and The Flow of Life: Keeping Your Dream Alive, which chronicles his life from childhood to adulthood.
As CEO of HCI, Dr. Mitchell is leading the medicinal and nutritional research division. HCI plans to partner with universities that are leading hemp and CBD research with a focus on disease prevention and treatment.